Low-cost ultrasensitive flexible carbon fiber-based biosensor for the detection of SARS-CoV-2 in human saliva

Abstract

The ongoing COVID-19 pandemic continues to have a significant impact on our daily lives, necessitating the rapid development of early diagnostic tools to mitigate the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks. In this context, biosensor technology has emerged as a highly promising strategy to address the challenges of low sensitivity, specificity, and high cost associated with clinical diagnosis. In this study, we present a novel and cost-effective approach for the rapid detection of SARS-CoV-2 using miniaturized flexible carbon fiber (FCF) electrodes that are modified with immunoglobulin G (IgG). Our strategy take advantage of on the antigen-antibody interaction (IgG-SARS-CoV-2) and leverages the surface chemistry characteristics of FCF to achieve signal amplification. Under standard conditions, we achieved a remarkable detection limit of 0.16 pg mmL−1 for the SARS-CoV-2 RBD protein. Additionally, when analyzing human saliva samples, our biosensing approach demonstrated good agreement with RT-PCR results, specifically for patients who tested positive for SARS-CoV-2. The sensitivity, selectivity, and accuracy of our approach were approximately 93.3%.

Keywords

• COVID-19
• SARS-CoV-2
• Ultrasensitive biosensor
• Flexible carbon fiber
• Human saliva